DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
Endroit courant :
>
> This Story


Ouverture ou Registre to rate this News Story
Forward Printable StoryPrint Comment

 

 

Business Affairs Homepage

Brainlab to become distributor of Elekta's stereotactic neurosurgery products in US Already the supplier in select European markets

Q&A with David Pacitti, President of Siemens Medical Solutions USA, Inc. and Head of Siemens Healthineers North America Insights from the show floor at RSNA

Hitachi acquires Mitsubishi Electric’s particle therapy system business Will integrate with Hitachi's own particle therapy division to form one entity

3-D printed middle-ear to correct hearing loss shows promise at RSNA Further evidence of CT and 3-D printing synergy

Edwards acquires Harpoon Medical Company now owns the image-guiding HARPOON System

Philips acquires VitalHealth for an undisclosed amount Adds to its population health management portfolio

Dignity Health, Catholic Health Initiatives agree to merge into giant, new Catholic health system Will provide care in 28 states

Image Diagnostics monitor to be enhanced with new video management system Add-on to the first large field 4k mobile and multi-modality monitor

Frans van Houten, CEO of Philips, on the future of radiology Discussing the demands for relevant innovations and the arrival of 'clinical data scientists'

Top 10 trends and takeaways from RSNA 2017 Are radiologists going the way of the dodo bird? Of course not / Yes, yes they are

Procedure with Profound's
TULSA-PRO system

Philips completes sale of MR-HIFU business to Profound Medical

par Lauren Dubinsky , Senior Reporter
Royal Philips announced today that it completed its business deal with Profound Medical Corporation.

Last month, the companies entered an asset and share purchase agreement. Profound agreed to acquire Philips' MR-Guided High Intensity Focused Ultrasound business in exchange for 7,400,000 Profound common shares.

Story Continues Below Advertisement

CT, MRI, NM, SPECT/CT, PET & PET/CT service, refurbished systems and parts

Accelerate your ROI with our Black Diamond Certified refurbished systems. One year warranty - ISO 13485 Certified - FDA registered - Over 65k parts in inventory



"We see a world where patients no longer need to choose between living well and living long, or between undergoing clinically effective procedures and returning quickly to their normal lives," Dr. Arun Menawat, CEO of Profound Medical, told HCB News. "By leveraging MR-guidance and ultrasound to deliver incision-free, inherently safe, personalizable, precise and cost-effective therapeutic solutions, we believe that we are well on our way toward realizing that vision."

Philips' Sonalleve MR-HIFU is used along with real-time MR imaging and thermometry to noninvasively ablate diseased tissue. To date, it has CE mark for the treatment of uterine fibroids and palliative pain associated with bone metastases.

Philips will continue to distribute Sonalleve for use with its Ingenia and Achieva MR systems. The company will also provide Profound with additional services such as manufacturing the MR-HIFU table and installations.

"The addition of Sonalleve to our offering benefits hospital customers by providing them with the ability to better utilize their MR system assets," said Menawat. "Our strengthened MR and ultrasound technology platform will accelerate the development of new clinical applications, while better serving the needs of our customers."

Philips is already a non-exclusive distributor of Profound's TULSA-PRO system and will continue to be. This system is designed for MR-guided prostate tissue ablation procedures.

Profound is now the only company that provides a therapeutics platform that combines real-time MR imaging and directional and focused ultrasound technology for ablating diseased tissue.

As part of the business agreement, Philips can purchase or sell securities of Profound "from time to time as it deems appropriate, based on market conditions and other circumstances."

However, Philips agreed not to sell, transfer or dispose of its interest in the common shares for one year after the completion of the transaction.

Business Affairs Homepage


You Must Be Logged In To Post A Comment

Publicité
Développez la notoriété de votre marque
Enchères + Ventes Privées
Obtenir le meilleur prix
Acheter des équipement / pièces
Trouver le meilleur prix
Infos du jour
Lire Les dernières nouvelles
Annuaire
Consulter tous les utilisateurs DOTmed
Éthique concernant DOTmed
Voir notre programme d'éthique
L'or partie le programme de fournisseur
Recevoir des demandes PH
Programme de marchand de service d'or
Recevoir des demandes
Fournisseurs de soins de santé
Voir tous les outils des HCP (abréviation pour les professionnels de la santé)
Les travaux/Formation
Trouver / combler un poste
Parts Hunter +EasyPay
Obtenir des devis de pièces
Certification Récentes
Voir les utilisateurs récemment certifiés
Evaluation Récentes
Voir les utilisateurs récemment certifiés
Central de location
Louer de l’équipement à moindre prix
Vendre des équipements / pièces
Obtenir le maximum d'argent
Service le forum de techniciens
Trouver de l'aide et des conseils
Simple demande de propositions
Obtenir des devis pour des appareils
Expo Virtuelle
Trouver des services d'appareils
L'Access et l'utilisation de cet emplacement est sujet aux modalités et aux conditions du notre de nos MENTIONS LEGALES & DONNEES PERSONELLES
Propriété de et classe des propriétaires DOTmedà .com, inc. Copyright ©2001-2017 DOTmed.com, Inc.
TOUS DROITS RÉSERVÉS